Interní Med. 2008; 10(11): 531-534

Pneumocystová pneumonie u HIV pozitivních osob

MUDr. Juraj Kultan
Klinika plicních nemocí a tuberkulózy, FN a LF UP Olomouc

Infekční postižení plic patří mezi nejčastější klinické projevy HIV infekce a podílí se významným způsobem na morbiditě a mortalitě nemocných, tato onemocnění většinou bývají součástí pokročilejších stadií již dříve diagnostikované HIV infekce. Typickým plicním postižením u HIV pozitivních osob je pneumonie vyvolaná Pneumocystis jiroveci (pneumocystová pneumonie – PCP). Někdy může být tato pneumonie prvním klinickým projevem dosud nepoznané HIV infekce, jak to ukazujeme na kazuistice pacienta, mladého, zdravého muže, který byl hospitalizován na našem pracovišti s velmi těžkou oboustrannou pneumonií. V další části textu popisujeme diagnostiku, léčbu a profylaxi pneumocystové pneumonie.

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kultan J. Pneumocystová pneumonie u HIV pozitivních osob. Interní Med. 2008;10(11):531-534.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alvarez-Martínez MJ, Miró JM, Valls ME, et al. Sensitivity and specificity of nested and real time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn. Microb. Infect. Dis. 2006; 56: 153-160. Go to original source... Go to PubMed...
    2. Cruciani M, Marcati P, Malena M, et al. Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients. Eur. Respir. J. 2002; 20: 982-989. Go to original source... Go to PubMed...
    3. Huang L, Morris A, Limper AH, et al. An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis pneumonia (PCP). The Proceedings of the American Thoracic Society, 2006; 3: 655-664. Go to original source...
    4. Luks AM, Neff MJ. Pneumocystis jiroveci pneumonia. Respiratory Care. 2007; 52: 59-63.
    5. Mansharamani NG, Garland R, Delaney D, et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV- associated cases to other immunocompromised states. Chest 2000; 118: 704-711. Go to original source... Go to PubMed...
    6. Maruna P. Proteiny akutní fáze. Praha: Maxdorf 2004: 198 s.
    7. Masur H. Pneumocystis carinii pneumonia. In: Shelhamer J, Pizzo PA, Parrilo JE et al. Respiratory disease in the immunosuppressed host. 1st ed. Philadelphia, J. Lippincott Company, 1991: 409-427.
    8. Miquez-Burbano MJ, Flores M, Ashkin D, et al. Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected subjects. Int. J. Infect. Dis. 2006; 1: 47-55. Go to original source... Go to PubMed...
    9. Skřičková J. Pneumocystová pneumonie. Klin. Farmakol. Farm. 2005; 19: 106-110.
    10. Skřičková J. Pneumocystová pneumonie - epidemiologie, diagnostika, léčba a profylaxe. Stud. Pneumol. Phthiseol. 2006; 66(5): 208-220.
    11. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am. J. Respir. Crit. Care Med 1997; 155: 60-66. Go to original source... Go to PubMed...
    12. Ševčík P, Skřičková J, Šrámek V, et al. Záněty plic v intenzivní medicíně. Praha, Galén: 2004: 143 s.
    13. Thomas CF, Limper AH. Pneumocystis pneumonia. NEJM. 2004; 350: 2487-2498. Go to original source... Go to PubMed...
    14. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo. Clin. Proc. 1996; 71: 5-13. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.